Interoceptive Exposure for Adolescents With Low Weight Eating Disorders
This study is comparing two behavioral therapies for adolescents aged 12-18 with Anorexia Nervosa (a serious eating disorder involving low body weight and food restriction). You might be eligible if you are aged 12-18, speak English, and have your pediatrician's permission for outpatient care. The study is testing two approaches: Interoceptive Exposure Treatment (IE), which targets food avoidance, and Family-Based Treatment (FBT), which involves parents helping to increase eating. Researchers want to see how much your body weight changes and if your clinical impairment improves after 6 and 18 months. The study aims to enroll 120 participants, but its current recruitment status is unclear.
- Study design
- This is a randomized controlled trial comparing two treatments, Interoceptive Exposure Treatment (IE) and Family-Based Treatment (FBT), and plans to enroll 120 participants.
- What's involved
- You would attend weekly sessions for 20 weeks, with the first session lasting 1.5 hours and subsequent sessions lasting one hour. Assessments will occur at 2, 4, 6, 12, and 18 months after the start of the study.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 12 months after treatment, with assessments at 6 and 18 months from baseline.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Interoceptive Exposure for Adolescents With Low Weight Eating Disorders
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Thomas Hildebrandt, Psy.D. · PRINCIPAL_INVESTIGATOR · Icahn School of Medicine at Mount Sinai
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Change in Expected Body Weight PercentageBaseline and 6-months
Expected body weight percentage will be calculated at baseline and end of treatment (6-months) to calculate difference.
- Change in Expected Body Weight PercentageBaseline and 18-months
Expected body weight percentage will be calculated at baseline and 1 year after treatment (18-months) to calculate difference.
- Change in ImpairmentBaseline and 6-months
Impairment is measured using the Clinical Impairment Assessment, which is a 16-item self-report measure of impairment from eating disorders. Responses are scored using 0, 1, 2, or 3 and the score is calculated using the sum of all items. Possible scores range between 0 - 48, with higher scores indicating more impairment and lower scores indicating less impairment. Change in impairment will be calculated using the baseline and end of treatment (6-months) scores from CIA.
- Change in ImpairmentBaseline and 18-months
Impairment is measured using the Clinical Impairment Assessment, which is a 16-item self-report measure of impairment from eating disorders. Responses are scored using 0, 1, 2, or 3 and the score is calculated using the sum of all items. Possible scores range between 0 - 48, with higher scores indicating more impairment and lower scores indicating less impairment. Change in impairment will be calculated using the baseline and 1 year after treatment (18-months) scores from CIA.